Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis
Clinical trial NCT01142726 · COMPLETED
Trial details
- NCT number
- NCT01142726
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2013-09-01
- Enrollment
- 511
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.